BackgroundCatalyzes the first and rate limiting step of the catabolism of the essential amino acid tryptophan along the kynurenine pathway. Involved in the peripheral immune tolerance, contributing to maintain homeostasis by preventing autoimmunity or immunopathology that would result from uncontrolled and overreacting immune responses. Tryptophan shortage inhibits T lymphocytes division and accumulation of tryptophan catabolites induces T-cell apoptosis and differentiation of regulatory T-cells. Acts as a suppressor of anti-tumor immunity. Limits the growth of intracellular pathogens by depriving tryptophan. Protects the fetus from maternal immune rejection.
DescriptionIDO1 Recombinant Monoclonal Antibody [9E5]. Unconjugated. Raised in: HEK293F Cell.
FormulationBuffer: Rabbit IgG in phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
SpecificityHuman
IsotypeRabbit IgG
Uniprot IDP14902
PurificationAffinity Chromatography
ImmunogenA synthesized peptide derived from human INDO
StorageUpon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Alternative NamesIndoleamine 2,3-dioxygenase 1 (IDO-1) (EC 1.13.11.52) (Indoleamine-pyrrole 2,3-dioxygenase), IDO1, IDO INDO
ApplicationELISA, IHC; Recommended dilution: IHC:1:50-1:200
Celebrate our 20th year anniversary with gifts on purchases above $300!
» Learn more
Cart (0)
